Drug Information Analysis Service

Work Group to Revise DSM-III. The diagnostic categories: Text and criteria. In: Diagnostic and statistical manual of mental disorders Revised. Washington, DC: American Psychiatric Association, 1987: 326–8.

Naylor MW Grossman M . Trichotillomania and depression. J Am Acad Child Adolesc Psychiatry 1991; 30: 155–6.

Hamdan-Allen G . Brief report: Trichotillomania in an autistic male. J Autism Dev Disord 1991; 21: 79–82.

Koran LM Ringold A Hewlett W . Fluoxetine for trichotillomania: An open clinical trial. Psychopharmacol Bull 1992; 28: 145–9.

Graae F Gitow A Piacentini J Jaffer M Liebowitz M . Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers. Am J Psychiatry 1992; 149: 149–50.

Kerbeshian J Burd L . Familial trichotillomania. Am J Psychiatry 1991; 148: 684–5.

Christenson GA MacKenzie TB Mitchell JE Callies AL . A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry 1991; 148: 1566–71.

Winchel RM Jones JS Stanley B Molcho A Stanley MI . Clinical characteristics of trichotillomania and its response to fluoxetine. J Clin Psychiatry 1992; 53: 304–8.

Swedo SE Leonard HL Rapoport JI Lenane MC Goldberger EL Cheslow DL . A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989; 321: 497–501.

Dech B Budow L . The use of fluoxetine in an adolescent with Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1991; 30: 298–302.

Alexander RC . Fluoxetine treatment of trichotillomania. J Clin Psychiatry 1991; 52: 88–9.

Primeau F Fontaine R . Obsessive disorder with self-mutilation: A subgroup responsive to pharmacotherapy. Can J Psychiatry 1987; 32: 699–701.

Sheikha SH Wagner KD Wagner RF Jr . Fluoxetine treatment of trichotillomania and depression in a prepubertal child. Cutis 1993; 51: 50–2.

Taylor KM . Aprotinin therapy and blood conservation: Extending the indications. Br J Surg 1992; 79: 1258–9.

Product information. Trasylol (aprotinin). West Haven, CT: Miles, 1994.

Westaby S . Aprotinin in perspective. Ann Thorac Surg 1993; 55: 1033–41.

Huang H Ding W Su Z Zhang W . Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993; 106: 11–8.

Lemmer JH Stanford W Bonney SL Breen JF Chomka EV Eldredge WJ . Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 1994; 107: 543–53.

Murkin JM Lux J Shannon NA Guiraudon GM Menkis AH McKenzie FN . Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994; 107: 554–61.

Bidstrup BP Harrison J Royston D Taylor KM Treasure T . Aprotinin therapy in cardiac operations: A report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993; 55: 971–6.

Grosse H Lobbes W Frambach M Ringe B Barthels M . Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation. Semin Thromb Hemost 1993; 19: 302–5.

Gerlach H Rossaint R Slama K Streich R Keitel M Blumhardt G . No requirement for cryoprecipitate or platelet transfusion during liver transplantation. Transplant Proc 1993; 25: 1813–6.

Suárez M Sangro B Herrero JI Picardi A Páramo JA Quiroga J . Effectiveness of aprotinin in orthotopic liver transplantation. Semin Thromb Hemost 1993; 19: 292–6.

Havel M Owen A Simon P Teufelsbauer H Zwoelfer W Laczkovics A . Decreasing use of donated blood and reduction of bleeding after orthotopic heart transplantation by use of aprotinin. J Heart Lung Transplant 1992; 11: 348–9.

Janssens M Joris J David JL Lemaire R Lamy M . High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology 1994; 80: 23–9.

Murphy JA Smith H Walker ID Davidson JF . Blood transfusion in cardiac surgery. Perfusion 1990; 5 (suppl):1–7.

Medi-Span hospital formulary pricing guide. Indianapolis: Medi-Span, 1994.

Lowenstein DH Alldredge BK . Status epilepticus at an urban public hospital in the 1980′s. Neurology 1993; 43: 483–8.

Bernard CG Bohm E Hojeberg ML . A new treatment of status epilepticus. In: Archives of Neurology and Psychiatry, Chicago: American Medical Association, 1955: 208–14.

Jagoda A Riggio S . Refractory status epilepticus in adults. Ann Emerg Med 1993; 22: 1337–48.

Package insert. Lidocaine HCl. Cherry Hill, NJ: Elkins-Sinn, 1990.

Katzung BG . Basic and clinical pharmacology. 5th ed. 1992: 203–4.

Aggarwal P Wali JP . Lidocaine in refractory status epilepticus: A forgotten drug in the emergency department. Am J Emerg Med 1993; 11: 243–4.

Morris HH III . Lidocaine: A neglected anticonvulsant? South Med J 1979; 72: 1564–6.

De Giorgio CM Altman K Hamilton-Byrd E Rabinowicz AL . Lidocaine in refractory status epilepticus: Confirmation of efficacy with continuous EEG monitoring. Epilepsia 1992; 33: 913–6.

Pascual J Sedano MJ Polo JM Berciano J . Intravenous lidocaine for status epilepticus. Epilepsia 1988; 29: 584–9.

Pascual J Ciudad J Berciano J . Role of lidocaine (lignocaine) in managing status epilepticus. J Neurol Neurosurg Psychiatry 1992; 55: 49–51.